SITARIO TRIO 500
Dapagliflozin, Sitagliptin & Metformin Hydrochloride (Extended Release)Tablets
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | SITARIO TRIO 500 |
| Active Formulation (Salt) | Dapagliflozin, Sitagliptin & Metformin Hydrochloride (Extended Release)Tablets |
| Dosage Form | TABLETS |
| Packaging Presentation | 10 x 1 x 10 Alu-Alu |
| Therapeutic Category | TABLETS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is SITARIO TRIO 500?
Therapeutic monograph and clinical profile
SITARIO TRIO 500 (Dapagliflozin, Sitagliptin & Metformin Hydrochloride (Extended Release)Tablets) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 10 x 1 x 10 Alu-Alu, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Type 2 Diabetes Management / Treatment Simplification.
Key Formulation Highlights
Why healthcare professionals recommend SITARIO TRIO 500
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Type 2 Diabetes Management / Treatment Simplification
Pharmacological Mechanism of Action
How SITARIO TRIO 500 acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for SITARIO TRIO 500
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for SITARIO TRIO 500 across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding SITARIO TRIO 500
What is SITARIO TRIO 500 used for?
What is the printed packaging and MRP of SITARIO TRIO 500?
How can I get monopoly PCD franchise for SITARIO TRIO 500?
Related Formulations in TABLETS
Explore complementary WHO-GMP certified healthcare formulations
